The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Obtaining FDA approval ( it must be very close) is very likely although cannot be guaranteed so I am surprised how many traders sold out over the last few weeks especially after the product launch in Europe. They must be happy with their 10% or 20%. I sincerely hope that there is no leak and that we wake up to an RNS soon as this will lock a lot of traders out who will miss the rise which should be significant as the ability to launch in US will be transformative. I expect that funds will be keen to buy in on FDA news too. Much to look forward to.
Looks like its going up now.
Why wouldn’t BOD release an RNS if sales were good & I think that’s the issue lack of news! As per usual FUM are useless at releasing news! Even when things are going well. This makes shareholders nervous instead of reassuring shareholders as things progress, for gods sake crunch the numbers & release an RNS.
Can someone rub some of this magic gel on the share price?
It needs to go up hard and strong
Kevin,
If this gel can please even 30% of men who actually try it, and they buy regularly, i have no doubt that with the opportunity across , hopefully (FDA allowing) the globe this company could be transformative.
as they say, you can have the best product in the world but if no one knows it exists, and where they can pick it up then it may as well never exist.
Its still early days, so hopefully the company will come up with a plan to educate the men of the UK, and Europe, and hopefully USA - pub toilets comes to mind, just above the urinals :).
Vascular this is sold in quite a few different countries so hopefully it will sell more purly being on more markets. What this share doesn’t need is an rns saying sales have been below expectations or ekse it will tank.
Long term this has great potential just needs some more pr. I’ve seen viagra and I think it’s called numan advertising recently so even after all these years they still advertise.
Maybe they are going for small growth to alllow the busines to ramp up you can’t go from nothing to the biggest player in the market without building up the infrastructure behind the scenes.
Think there is lots of board rooms infested with Tsetse flies including this one .
Just to be boring...the application for FDA approval is a fact (which the board stated were optimistic of positive outcome), the guesswork/rumour is the timing of the response.
RPG7
"I would guess that half the so called investors have no idea what the company does" .
If anyone finds out could they please enlighten me. (Surely, they can not outsource and then sit on their hands)
Looked at Erexcon to buy,,, TWO MONTH DELIVERY! WTF,,,,,
Surprised they have gone to Amazon, would have thought places like Lloyd's Pharmacies & Super drug would be more suitable.
With Amazon sales, who would be the supplier - will that be Coopers - and would we expect to see reviews or can a seller omit that feature ?
Indeed but thats guesswork not a rumour.
The rumour that they applied for FDA approval months ago, so by deduction the decision is due soon.
Banzai, what rumour? Are you bored?
Its all about the' angle of dangle' trading ,nothing to do with the company or the product .I would guess that half the so called investors have no idea what the company does .
Rumour has it that FDA approval is imminent.
If you look at the sp chart, that old adage "buy on rumour, sell on news" seems to have played out here, as sp now back to last Novembers price, even after EU & UK initial launch and FDA approval pending. Funny business this game.
After a day or two of excellent media coverage in UK, there appears to be nothing advertised.
If you think V. positively, that for every four men who give it a try, one, maybe two will continue to buy it regularly then FUM need to get as many men in the UK to try it at least once.....as possibly 50% or more of the men who try it after the media burst may not buy it again - so it should be an ongoing advertising campaign to increase sales otherwise we will be just relying on the 50% who heard about it on release.
Hopefully, they have a longer term plan.
Evening,
Has anyone seen this product advertised? With such an incredible product they need to promote it more. I’ve not seen it advertised once and I’m on the look out for it. ( as an interested party not a user fyi)
The link will work for any company, just replace the PLE ticker with whatever you are looking for
And anyone else who may be interested.
LSE have said "Delisted companies not showing is a temporary glitch that should be resolved soon".
The.Italian try this link:
https://www.lse.co.uk/SharePrice.html?shareprice=PLE
Seems to work. :-)
BJ
The point I was making was that if they decide to unload, through a brokerage house, perhaps.
It seems like a racket the way Amazon sells this. On the one hand you have a seller selling it at an inflated price which then allows the Amazon stock sell, to show as an artificial 50% reduction.
But on another point, I contacted the company two years back suggesting that they protect themselves re the name and warned them to purchase additional domains of products that could imitate the brand name. Specifically 'erexon'
81l surely as brokers cannot act as principals this is not a progùblem
Totally agree, LO are among six entities that can cause game changing movements in the SP. This includes the current management.
However, any selling by these would only be relevant if it was backed up by solid motivation.
Regarding the numbers, LO appear to be just tinkering at the edges. A worrying event would be if they placed significant holding with a broker.
Until we get first indication of sales or FDA news (or some unforeseen event) , this is likely to be the trend and a muse for traders and day traders.